Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03787264 |
|---|---|
| Brief Title: | Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL (CLL2-BAAG) |
| First Submitted : | December 20, 2018 |
| First Submitted that Met QC Criteria : | December 22, 2018 |
| First Posted : | December 26, 2018 |
| Last Update Submitted that Met QC Criteria : | November 8, 2022 |
| Last Update Posted : | November 9, 2022 |